TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
SBM Life Science AB
Closing information (x1000 NOK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
176,393
|
205,433
|
202,810 |
Financial expenses |
5,947
|
5,088
|
2,920 |
Earnings before taxes |
-1,333
|
4,040
|
5,207 |
EBITDA |
3,761
|
8,615
|
7,740 |
Total assets |
102,720
|
159,884
|
86,137 |
Current assets |
101,665
|
158,956
|
84,170 |
Current liabilities |
86,423
|
142,742
|
71,594 |
Equity capital |
16,298
|
17,142
|
14,542 |
- share capital |
49
|
48
|
50 |
Employees (average) |
18
|
19
|
27 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
15.9%
|
10.7%
|
16.9% |
Turnover per employee |
9,800
|
10,812
|
7,511 |
Profit as a percentage of turnover |
-0.8%
|
2.0%
|
2.6% |
Return on assets (ROA) |
4.5%
|
5.7%
|
9.4% |
Current ratio |
117.6%
|
111.4%
|
117.6% |
Return on equity (ROE) |
-8.2%
|
23.6%
|
35.8% |
Change turnover |
-33,648
|
10,820
|
9,093 |
Change turnover % |
-16%
|
6%
|
5% |
Chg. No. of employees |
-1
|
-8
|
-3 |
Chg. No. of employees % |
-5%
|
-30%
|
-10% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.